Digital Health Global

FEBRUARY 26, 2024

Ltd has submitted Akili’s digital therapeutic SDT-001 for marketing approval with the Ministry of Health, Labor, and Welfare. Food and Drug Administration (FDA) as the world’s first prescription digital therapeutic for improving attentional functioning in pediatric ADHD patients aged 8 to 17. About Shionogi & Co.

Pharmaceuticals 167

Pharmaceuticals Digital Health Public Health 167

Digital Health Global

DECEMBER 18, 2023

Food and Drug Administration (FDA) to expand the label for EndeavorRx ® from 8 to 12 year-old patients with primarily inattentive or combined-type ADHD who have a demonstrated attention issue to include older children aged 13 – 17. A prespecified responder analysis also showed that 27.1%

Digital Health 88

Digital Health Mental health Public Health 88

Digital Health Global

FEBRUARY 27, 2024

Ltd has submitted Akili’s digital therapeutic SDT-001 for marketing approval with the Ministry of Health, Labor, and Welfare. Food and Drug Administration (FDA) as the world’s first prescription digital therapeutic for improving attentional functioning in pediatric ADHD patients aged 8 to 17.

Pharmaceuticals 88

Pharmaceuticals Digital Health Public Health 88

Digital Health Global

JUNE 7, 2023

Amid growing mental health crisis, the product release enables immediate access to non-drug treatment option as Akili prepares FDA submission Available nationwide without a prescription, clinical data shows improvements in focus in 83% of adults with ADHD BOSTON–(BUSINESS WIRE)– $AKLI #ADHD –Akili, Inc.

Mental health 88

Mental health Digital Health Psychiatry Public Health 88

Digital Health Global

SEPTEMBER 21, 2023

Clinical trial data show that 83% of adults with ADHD experienced improved focus, and 73% reported improvement in quality of life after EndeavorOTC treatment Available nationwide without a prescription, EndeavorOTC users can now access their personalized Focus Score and track progress towards clinically-meaningful improvements in attention.

Digital Health 88

Digital Health Mental health Public Health 88

Telebehavioral Health Institute

OCTOBER 27, 2022

Done Global is a digital therapeutics company specializing in the remote treatment of Attention Deficit and Hyperactivity Disorder (ADHD). Both organizations are active on social media, often overstating the benefits of ADHD medications. . Done Global Clinicians Complain of Undue Pressure for ADHD Diagnosis.

Telehealth 75

Telehealth Public Health 75

Telebehavioral Health Institute

OCTOBER 27, 2022

Done is a digital therapeutics company specializing in the remote treatment of Attention Deficit and Hyperactivity Disorder (ADHD). In recent months, the US Drug Enforcement Agency (DEA) has been investigating the telehealth prescription practices of digital therapeutics companies specializing in behavioral care.

Telehealth 75

Telehealth Public Health 75